| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Serine/threonine-protein kinase pim-2 |
|---|
| Ligand | BDBM50385064 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_821479 (CHEMBL2038009) |
|---|
| IC50 | 5000±n/a nM |
|---|
| Citation |  Tsuhako, AL; Brown, DS; Koltun, ES; Aay, N; Arcalas, A; Chan, V; Du, H; Engst, S; Franzini, M; Galan, A; Huang, P; Johnston, S; Kane, B; Kim, MH; Laird, AD; Lin, R; Mock, L; Ngan, I; Pack, M; Stott, G; Stout, TJ; Yu, P; Zaharia, C; Zhang, W; Zhou, P; Nuss, JM; Kearney, PC; Xu, W The design, synthesis, and biological evaluation of PIM kinase inhibitors. Bioorg Med Chem Lett22:3732-8 (2012) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Serine/threonine-protein kinase pim-2 |
|---|
| Name: | Serine/threonine-protein kinase pim-2 |
|---|
| Synonyms: | PIM2 | PIM2_HUMAN | Pim-2h | Serine/threonine-protein kinase (PIM2) | Serine/threonine-protein kinase PIM | Serine/threonine-protein kinase pim-2 (PIM2) |
|---|
| Type: | Serine/threonine-protein kinase |
|---|
| Mol. Mass.: | 34185.93 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q9P1W9 |
|---|
| Residue: | 311 |
|---|
| Sequence: | MLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAI
KVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPL
PAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKL
IDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER
DQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKG
GPAPLAWSLLP
|
|
|
|---|
| BDBM50385064 |
|---|
| n/a |
|---|
| Name | BDBM50385064 |
|---|
| Synonyms: | CHEMBL2035612 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C17H12ClN3O2 |
|---|
| Mol. Mass. | 325.749 |
|---|
| SMILES | CNc1ccc2oc3c(nc([nH]c3=O)-c3ccccc3Cl)c2c1 |
|---|
| Structure | 
|
|---|
Search and Browse
